Towards a global objective to produce chemical derivatives by microbial processes, this work dealt with a metabolic engineering of the yeast Saccharomyces cerevisiae for glycerol production. To accomplish this goal, overexpression of GPD1 was introduced in a tpi1D mutant defective in triose phosphate isomerase. This strategy alleviated the inositol-less phenotype of this mutant, by reducing the levels of dihydroxyacetone phosphate and glycerol-3-P, two potent inhibitors of myo-inositol synthase that catalyzes the formation of inositol-6-phosphate from glucose-6-phosphate. Further deletion of ADH1 and overexpression of ALD3, encoding, respectively, the major NAD + -dependent alcohol dehydrogenase and a cytosolic NAD + -dependent aldehyde dehydrogenase yielded a yeast strain able to produce 0.46 g glycerol (g glucose)
Introduction
Glycerol is one of the most important by-products of glucose conversion during alcoholic fermentation by Saccharomyces cerevisiae. This metabolite can reach 0.1 g per g glucose consumed under anaerobic condition to equilibrate the redox balance by regenerating NADH associated with the biomass production during the fermentation (Overkamp et al., 2002; Remize et al., 1999) . Glycerol is also involved in osmoregulation (for a review see (Hohmann, 2002) , and can act as a cryoprotectant like trehalose (Izawa et al., 2004) . As shown in Fig. 1 , glycerol is synthesized in the yeast S. cerevisiae in a two reaction process, consisting of the reduction of dihydroxyacetone phosphate (DHAP) by a NAD + -dependent glycerol-3-phosphate dehydrogenase (GPD), followed by the dephosphorylation of glycerol-3-phosphate (glycerol-3-P) by a glycerol-3-phosphate phosphatase (GPP) (Albertyn et al., 1994b; Ansell et al., 1997; Pahlman et al., 2001 ). GPD1 and GPD2 encode the two isozymes of GPD (Larsson et al., 1993) and GPP1 and GPP2, those of GPP (Pahlman et al., 2001) . These genes are subject to different control, e.g., expression of GPD1 and GPP2 are increased in response to an osmotic stress, while GPD2 and GPP1 are induced under anaerobic condition (Albertyn et al., 1994b; Ansell et al., 1997; Costenoble et al., 2000; Pahlman et al., 2001) . Based on these considerations and on other genetic data, it is assumed that the couple Gpd1p/Gpp2p is the major route for glycerol production under aerobic condition, whereas Gpd2p/Gpp1p play a specific role in redox balance under anaerobic growth conditions (Blomberg, 1997; Hohmann, 2002) . Additionally, the distinct localization of Gpd1p and Gpd2p may also explain that the former cannot substitute for the latter in mitochondrial defective strains (Valadi et al., 2004) .
The yeast S. cerevisiae is not only a good glycerol producer, it is also the most useful system to evaluate various engineering strategies to optimize the synthesis of this product. Over the past decade, there have been several attempts at manipulating yeast metabolism to optimize glycerol production by shifting from a bioprocess-mediated mode involving sulphite to a reprogramming of the cellular metabolism by recombinant DNA technology. The latter strategy has been relatively successful since it raised the glycerol production from 0.25 g glycerol (g glucose)
À1
obtained by the sulphite bioprocess (Bisping and Rehm, 1988; Petrovska et al., 1999) to 0.42 g glycerol (g glucose)
by a metabolic engineering strategy that involved a deletion of TPI1 encoding triose phosphate isomerase and the removal of the cytosolic NADH reoxidation by mitochondrial redox shuttles (Overkamp et al., 2002) . In a recent paper, Pronk and coworkers could reach a glycerol yield close to 0.50 g glycerol (g glucose) À1 by another genetic engineering strategy that overcame TPI1 deletion, but that required a disruption of genes encoding respiratory chainlinked NADH dehydrogenase and pyruvate decarboxylase (Geertman et al., 2006) .
In spite of the relative technological advantages of using S. cerevisiae to put into practice various genetic strategies, the remaining challenge is to get the maximal glycerol yield at the fastest rate. This achievement requires a reduction of the contribution of assimilatory glucose metabolism to anabolic and maintenance purposes and an increase in the NADH availability. These two constraints could eventually be overcome by a comprehensive investigation of the consequences of the genetic engineering strategies at the metabolic and genomic levels. As depicted in Fig. 1 , our strategy comprised the over-expression of GPD1 encoding glycerol phosphate dehydrogenase, followed by a disruption of TPI1 and ADH1, which encode, respectively, the triose phosphate isomerase and the major alcohol dehydrogenase. In addition, we evaluated whether the overexpression of a NAD + -dependent aldehyde dehydrogenase encoded by ALD3 (Navarro- Avino et al., 1999) could reduce the increased levels of acetaldehyde generated by these genetic modifications in favour of a supplementary provision of NADH for glycerol production. Overall, this strategy yielded an engineered strain that was able to produce 0.46 g glycerol (g glucose) À1 at a production rate of 3.1 mmol (g biomass h)
À1 . Our metabolic and transcriptomic analyses of the engineered strains highlighted many cellular targets that can be responsible for restraining yeast cells for higher glycerol productivity.
All S. cerevisiae strains constructed in this study are listed in Table 1 . The host strain was the wild type auxotrophic strain of the diploid CEN.PK2 family described in van Dijken et al. (2000) . Gene were integrated/deleted into/from yeast genome by homologous recombination following the transformation procedure of Woods and Gietz (2001) . Verification of genetic modification was carried out by diagnostic PCR using specific primers listed in Table 2 . Selective media for yeast transformants and genetic manipulation of yeast cells for sporulation and tetrad dissection were carried out as described (Rose et al., 1990) .
For overexpression of GPD1 in CEN.PK2, the ORF (1176 bp) was amplified by PCR from genomic DNA using primers HC1 and HC2, flanked with HindIII linkers (restriction site underlined in Table 2 ). The PCR fragment was cloned into the pGEMT (purchased from Promega) to yield pHC1. ADH1 promoter and terminator were amplified by PCR using the plasmid pODB80 (Louvet et al., 1997) as DNA template with primers HC3 and HC4 for ADH1 promoter, and HC5 and HC6 for ADH1 terminator, respectively ( Table 2 ). The primers were designed to create a HindIII cloning site between ADH1 promoter and terminator. This amplification generated two fragments (705 pb and 193 bp) that were cloned together in the XhoI/ SpeI sites of pRS305 to generate pHC12. Then, the 1176 bp HindIII fragment of pHC1 was cloned into the HindIII cloning site of pHC12 to yield pHC13 (GPD1 ORF under the ADH1 promoter). The diploid strain CEN.PK2 was transformed with the linearized pHC13 plasmid (cut by EcoRI in the LEU2 marker) and transformants were selected on SD leu À selective medium to retain one clone of each opposite mating type (HC13 a and HC13 a) that was verified by PCR for correct integration of GPD1 at the Leu locus. The two clones were crossed to get HC13 a/a diploid cells.
Mutant strain deleted for TPI1 and overexpressing GPD1 was constructed as follows. TPI1 encoding triose isomerase was disrupted using the loxP-KanMX4-loxP cassette (Guldener et al., 1996) that was PCR-amplified with 40bp homologous to yeast TPI1 gene flanked upstream and downstream of the cassette using primers HC9 and HC10 (Table 2 ). The purified cassette was used to transform the diploid HC13 a/a strain. Transformants were selected on YPD medium containing 0.2 g l À1 G418 according to Wach et al. (1994) . Heterozygote clones identified by PCR for correct disruption of TPI1 was then sporulated and dissected on MO (1% yeast extract, 2% bactopeptone, 0.1% glucose and 2% ethanol) agar plate and then replica plated on YPD+0.2 g l À1 G418, SD supplemented with leucine, uracil, tryptophane and histidine, and SD supplemented with same auxotrophic requirements except leucine, both media also containing 100 mM myo-inositol to select for tpi1D and tpi1D GDP1-overexpressing clones.
Deletion of ADH1 was also obtained by the short flanking homology method using pUG6 as the template (Guldener et al., 1996) . The cassette was used to transform CEN.PK2 diploid strain, and the haploid strain HC17 was isolated after sporulation of one ADH1/adh1D heterozygous diploid. Overexpression of ALD3 encoding a cytosolic NAD + -dependent aldehyde dehydrogenase (Navarro-Avino et al., 1999; White et al., 2003) was carried out by PCR amplification of the ALD3 ORF using genomic DNA in two step procedure, because of the high identity shared with ALD2 (98%). In the first step, the gene (from À73 to +1684) was amplified using primers HC13 and HC14 (Table 2 ) and subcloned into pGEMT. In a second step, the ALD3 ORF (from ATG to stop codon) was amplified with HC15 and HC16 (each primer contained a PstI linker at their 5 0 end) and recloned into pGEMT to 
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Materials and methods
Construction of engineered yeast strains yield pHC24. To express ALD3 under ADH1 promoter, we modified pRS304 as follows. The ADH1 promoter and terminator were amplified by PCR from pODB80 using primers HC17 and HC18 (for ADH1 promoter) and HC19/ HC20 (for ADH1 terminator). These primers bear at their 5 0 end a PstI cloning site and they were cloned into KpnI and SacI sites of the integrative plasmid pRS304 (Sikorski and Hieter, 1989) . Then, ALD3 ORF from pHC24 was digested by PstI and cloned into the modified pRS304 to yield pHC23. This plasmid was linearized by cutting in the TRP1 marker with XbaI to target homologous recombination at TRP1 locus into HC23 strain. Transformants were selected on SD trp À medium. Haploid strain HC30 (leu2HGPD1-LEU2 tpi1HKanMX trp1HALD3-TRP1 trp1 ura3 his3) was obtained from diploid HC16 Â HC30 (MATa leu2HGPD1-LEU2 tpi1HKanMX4 trp1 ura3 his3) and HC23 (MATa leu2HGPD1-LEU2 trp1HALD3-TRP1, trp1 ura3 his3) by tetrad analysis. The presence of GPD1 and ALD3 cassettes and tpi1D disruption was checked by PCR. This allowed us to isolate the haploid strain HC30 (leu2HGPD1-LEU2 trp1HALD3-TRP1 tpi1HKanMX4 ura3 his3). Strain HC32 (adh1HKanMX4 leu2HGPD1-LEU2, tpi1HKanMX4 trp1 ura3 his3) was obtained by crossing HC16 (MATa leu2HGPD1-LEU2 tpi1HKanMX4 trp1 ura3 his3) with HC17 (MATa adh1HKanMX4 leu2, trp1 ura3 his3). This haploid strain HC32 was also transformed with the linearized integrative pHC23 plasmid to integrate ALD3 at the TRP1 locus by homologous recombination to yield HC42. For overexpression of FPS1 in HC42, the ORF was amplified by PCR from genomic DNA using to primers HC_FPS1HS and HC_FPS1HAS, flanked with HindIII linkers. The PCR fragment was cloned in pGEMT (digestion HindIII). The generated fragment was subcloned into the HindIII cloning site of pHC 32 (URA3 marker) under ADH1 promoter, to yield pHC33. This plasmid was linearized by cutting the URA3 marker with EcoRV in order to introduce the construct by homologous recombination at the URA3 locus into HC42 strain. Transformants were selected on SD ura À medium, and selected clones were verified by PCR for correct integration.
To assess for growth efficiency, the wild type and engineered yeast strains were cultivated at 30 1C in 0.5 l Erlenmeyer flasks containing 150 ml of the following media: YPD (2% peptone, 1% yeast extract, 2% glucose), MO (2% peptone, 1% yeast extract, 0.1% glucose, 1% glucose and completed with auxotrophic requirements) buffered at pH 5.0 by addition of 85 mM sodium succinate pH 5.0. Growth was followed by measurement of absorbance at 600 nm. For cultivation in bioreactors, a loopful of the stock culture was inoculated into two 0.5 l Erlenmeyer flasks containing 150 ml of SD medium supplemented with auxotrophic requirements at 200 mg ml À1 , and incubated on a rotary shaker at 150 rpm. After 24 h of cultivation at 30 1C, the volume necessary to start the fermentation with 0.05 OD was harvested by centrifugation and the pellet was transferred to a 2-l bioreactor (Biostat MD, Braun, Melsungen, Germany) containing 1.5 l of the same medium as in shake flasks. Cultures were carried out at 30 1C, with continuous stirring at 150 rpm and an aeration rate of 0.5 vvm. The pH was maintained at 5.0 by automatic addition of NaOH 1 M.
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The wild type strain and engineered HC42 strain were harvested in early log phase (OD 600 ¼ 1.0 unit) by centrifugation from four independent cultures made in SD. The frozen cells (equivalent to 10 unit OD 600 ) were mechanically disrupted (MicroDismembrator Braun, Melsungen) and total RNA was isolated using RNeasy Mini kit (Qiagen) following the protocol of the manufacturer. The quantity and the quality of the extracted RNA were determined by microcapillary electrophoresis using a Bioanalyzer 2100 (Agilent Technologies, Wilmington, DE, USA). Incorporation of Cyanine 3-and Cyanine 5-dCTP (Amersham Bioscience) was performed during reverse transcription of total RNA using LabelStar Reverse Transcriptase (Qiagen). Labelled cDNA was purified on MinElute spin columns (Qiagen) and was hybridized on dendrimer-activated glass slides, which bears the whole yeast genome by covalently attached DNA probes (70-mer oligonucleotides) made according to LeBerre et al. (2003) . Hybridization was carried out in an automatic hybridization chamber (Discovery from Ventana Medical System, Inc) for 10 h at 42 1C. After hybridization, the slides were washed in 2 Â SSC/0.2% (v/v) SDS, immersed briefly in isopropanol and then dried under a stream of air. Biological replicates of DNA arrays experiments were made by using total RNA that were extracted from four independent cultures (four cultures for both wild type and the engineered strains). Transcripts from two independent cultures (for both wild type and engineered strains) were retro transcribed using dCTP-CY3, and the two other reciprocally with dCTP-CY5. The labelled cDNA from wild type and engineered strain were competitively hybridized on DNA microarrays. This resulted in four DNA arrays, with eight intensity values for each gene, since each gene was represented 2 times on an array. The hybridization signal was detected by scanning using GenePix 4000B laser Scanner (Axon Instruments), and the signal quantification was transformed to numerical values using the integrated GenePix software version 3.01.
The data were statistically treated using Bioplot/Bioclust software accessible at http://biopuce.insa-toulouse.fr/ ExperimentExplorer/doc/BioPLot/. Briefly, raw intensities were corrected for the local background, log transformed and normalized by the mean log-intensity of all spots. Logratios of normalized intensities from quadruplicate samples were tested for statistical significance using Student's t-test with Benjamini and Hockberg test correction (Hochberg and Benjamini, 1990 ) with a prediction for false discovery rate to about 5% of the genes identified. The differentially expressed genes were further narrowed with fold changes in expression of at least 1.5-fold. They were classified according to functional categories following MIPS (http://mips.gsf.de/ proj/funcatDB/search_main_frame.html). Other publicly available Web resources for data expression analysis were used including Go Term Finder (http://yeastgenome.org) and FunSpec (http://funspec.med.utoronto.ca/) for Gene ontology classification and YEASTract (http://www. yeastract.com/) to search for transcriptional factors.
Crude extracts were prepared by vortexing at 4 1C 4 times 30 s, about 25 mg (dry mass) yeast cells with 1 g glass beads (0.4-0.5 mm diameter) with 0.5 ml of 20 mM Hepes pH 7.1, 20 mM KCl, 1 mM EDTA, 1 mM DTT and protease inhibitor cocktail from Boehringer (1 capsule for 10 ml of buffer). After centrifugation at 8000g for 15 min at 4 1C, the supernatants were used for enzymatic assays. Glycerol-3-phosphate dehydrogenase and glycerol-3-phosphate phosphatase activities were determined as described by Gancedo et al. (1968) , except that the reaction buffer was 20 mM Hepes, pH 7.1, and the final concentration of DHAP and glycerol-3-P were 5 and 10 mM, respectively. The NAD + and NADP + -dependent glycerol-dehydrogenase were measured according to Vries et al. (2003) at pH 7.1 or pH 9.0. NAD + and NADP + -dependent acetaldehyde dehydrogenase activities were measured according to Postma et al. (1989) . Alcohol dehydrogenase activity was determined in 50 mM KH 2 PO 4 , pH 8.0 in the presence of 1.0 mM NAD + and the reaction was started by the addition of 100 mM ethanol. Glucose-6-phosphate dehydrogenase (G6PD) and glucose-6-phosphate isomerase (PGI) were measured in 20 mM Hepes, pH 7.1 in the presence of 0.4 mM NADP + . For G6PD, the reaction was started with 4.5 mM glucose-6-phosphate. For PGI activity, the reaction mixture also contained 1 U ml À1 glucose-6-phosphate-dehydrogenase (Sigma) and was started by addition of 1.5 mM fructose-6-phosphate. The enzymatic assays were performed at 30 1C. Protein concentration was determined with the Bradford method (Bio-Rad Kit assay n1 500-002) using bovine serum albumin as a standard.
Glucose, glycerol, ethanol, acetate, acetoin and acetaldehyde were determined in the growth medium with commercial biochemical kits or by high performance liquid chromatography. In the latter case, the supernatant was filtered through 0.22 mm-pore-size nylon filters prior to loading on a HPX-87H Aminex ion exclusion column. The column was eluted at 30 1C with 1 mM H 2 S0 4 at a flow rate of 0.5 ml min À1 and the concentration of the compounds was determined using a Waters model 410 refractive index detector. Intracellular metabolites were extracted from whole yeast cells as described in Gonzalez et al. (1997) , except for DHAP and glycerol-3-phosphate, which were extracted in 10% HClO 4 according to Franc -ois et al. (1984) . These two latter metabolites as well as NAD + and NADH were measured by fluorescence spectrophotometry (excitation wavelength 340 nm, emission wavelength 460 nm) using enzymatic coupled reaction as described (Klingenberg, 1974) . Extracellular organic acids were determined by high performance ionic chromatography (HPIC) using a Dionex Bio-LC500 apparatus as described previously (Groussac et al., 2000) . Pi was measured in crude extract according to Bencini et al. (1983) . For measuring intracellular glycerol, 20 ml of cell sample were quickly filtrated onto 0.45 mm nitrocellulose filter, washed once by 20 ml of À20 1C 60% methanol solution. The filters were immersed into 2 ml of cold water and the tubes were put for 10 min in a water bath set at 90 1C. After centrifugation of the cells debris at 10,000 g for 5 min, glycerol was measured in the supernatant by a NADH-coupling enzymatic assay at 340 nm. The reaction was done in 50 mM TrisCl pH 7.4 containing 5 mM MgCl 2 , 1 mM NAD + and 1 U ml À1 glycerol-3-phosphate dehydrogenase (from Roche, Mannheim, Germany).
Results
In a well-aerated glucose synthetic medium (20 g l À1 glucose), the production of glycerol by the wild type yeast strain (CEN.PK2) reached a maximum of 2.070.4% of the glucose consumed (Table 3 ). This level of glycerol can be explained in part by the fact that yeast cells are endowed with other redox systems for maintaining the intracellular NAD + /NADH balance (Bakker et al., 2001) , and also because the NAD + -dependent glycerol-3-P-dehydrogenase (GPD) that catalyzes the reduction of DHAP into glycerol-3-P is rate-limiting for glycerol production (Cronwright et al., 2002; Larsson et al., 1993; Nevoigt and Stahl, 1996; Remize et al., 2003) . Therefore, it was obvious to evaluate at first side effects of overproduction of this enzyme. To this end, the GPD1 ORF was fused upstream of a strong ADH1 promoter and this construct was integrated at the leu2 locus in the genome of the strain CEN.PK2. Table 3 shows that the glycerol yield in the GPD1-overexpressing strain was 10-fold higher than in the wild type (Table 4) and this rise of production was in the same order of magnitude as the increase of glycerol-3-phosphate dehydrogenase activity in the transformed strain, which indicates that a large part of the flux control in glycerol pathway is hierarchical (ter Kuile and Westerhoff, 2001) .
Increasing the availability of NADH is an additional mode that may favour glycerol production. This suggestion can be directly evaluated by deleting TPI1 encoding triose phosphate isomerase, since this genetic intervention should redirect half of the glucose molecule into the glycerol pathway (see Fig. 1 ). However, the downside of this intervention is the inability of a tpi1D mutant to grow on a minimal glucose medium (Campagno et al., 1996; Overkamp et al., 2002) our data not shown), because of its inositol defective phenotype (Shi et al., 2005) . This phenotype was shown to be a consequence of the inhibition of the myo-inositol synthase encoded by INO1 by high levels of DHAP accumulating in tpi1D mutants. Interestingly, the overexpression of GPD1 restored the growth of the tpi1D mutant, although the maximal growth rate of the tpi1DGPD1-overexpressing strain was still 4 times lower than that of the isogenic wild type. Taken together, this strategy yielded a glycerol producer strain that exhibited a glycerol production yield of 0.36 g (g glucose) À1 , similar to that of the quadruple tpi1Dnde1Dnde2Dgut2D mutant Table 3 Growth rate, yield of biomass and fermentation products in engineered strains for glycerol production obtained from shake flask cultures Growth was carried out in SD medium at pH 5.0 as described in Material and methods. Yield for each metabolites was determined at the time of the complete consumption of glucose from the medium and it is expressed as 'g product per 100 g glucose'. Values of yield are the mean7standard deviation from four independent experiments. nd ¼ not determined.
Analytical procedures
Construction of a glycerol hyper producer strain reported earlier (Overkamp et al., 2002) . However, this latter engineered strain as analysed prior to its adaptation to high sugar concentration, had a maximal growth rate 2 times lower than that of our tpi1D mutant overexpressing GPD1 strain (0.045 h À1 versus 0.10 h À1 ). Another option for increasing glycerol production was to remove the major alcohol dehydrogenase encoded by ADH1, since this genetic intervention should also favour NADH reoxidation through glycerol formation (Fig. 1) . The glycerol yield of the adh1 mutant was found to be comparable to that of the GPD1-overexpressing strain. Moreover, the deletion of ADH1 resulted in a 2-fold reduction of the maximal growth rate (Table 3) . This reduction could be due to an insufficient rate of reoxidation of NADH by the native GPD1 and/or to an accumulation of acetaldehyde, a potential toxic molecule for growth (Michnick et al., 1997 ). An argument in favour of the first suggestion was the fact that the adh1D mutant recovered the wild type growth rate upon overexpression of GPD1 (0.40 h À1 for the adh1DGPD1 versus 0.44 h À1 for the wild type, Table 3 ). Nevertheless, the yield of glycerol from glucose was not improved in the adh1 mutant that overexpressed of GPD1 (data not shown). A further possibility to enhance NADH availability could be to promote the conversion of pyruvate to acetate via pyruvate decarboxylase and NAD + -dependent aldehyde dehydrogenase-driven reactions (see Fig. 1 ). ALD3 which encodes a cytosolic NAD + -dependent aldehyde dehydrogenase reported to be implicated in alanine biosynthesis (White et al., 2003) was overexpressed with the expectation that this enzyme could act on acetaldelyde to form acetate. Contrary to expectation, this genetic construct only slightly increased the glycerol yield when integrated in a tpi1DGPD1 mutant to yield HC30 strain, and had no effect in a GPD1-overexpressing strain. We therefore evaluated the combination of GPD1 overexpression with the deletion of TPI1 and ADH1 on glycerol production.
The resulting engineered HC32 strain exhibited a glycerol yield of 0.46 g (g glucose) À1 , which equalled the yield of the engineered S. cerevisiae strain lacking pyruvate decarboxylase activity and mitochondrial-localized NADH dehydrogenases (pdc1D pdc2D pdc5D nde1D nde2D gut2D) constructed by Geertman et al. (2006) . However, a significant production of ethanol of about 0.1 g (g glucose)
À1 still took place in these engineered strains, which could be attributed to the 5% residual alcohol dehydrogenase activity from expressed minor ADH genes (Drewke et al., 1990) . The last step was to overexpress ALD3 in HC32 strain. Because in shake flasks cultures, we observed a weak but reproducible 5-10% increase in glycerol production due to this gene overexpression (data not shown) that was not really confirmed in controlled batch cultures, we were inclined to use that latter engineered strain for further characterization of glucose fermentation and for evaluating the consequences of the genetic strategy by a comparative metabolic and genomic study to the isogenic wild type strain. Fig. 2 shows the growth curve and by-products formation of wild type, HC16 (tpi1DGPD1) and HC42 (tpi1D adh1D ALD3 GPD1) strains growing on a glucose minimal medium in pH-controlled batch fermentors. Since the three cultures were inoculated with the same amount of cell biomass, it could be seen that the time required for complete consumption of glucose by the engineered strains (HC16 and HC42 strains) was greater than that of the isogenic wild type. However, the HC42 was able to ferment glucose more rapidly than HC16, suggesting a regain of growth efficiency as a consequence of a better management of NADH regeneration due to the loss of ADH1 function and/or to the increased expression of ALD3 in HC42. Also, The values are the mean7SD of three independent experiments. G6PD ¼ glucose-6-P dehydrogenase; PGI ¼ glucose-6-phosphate isomerase; GPD ¼ glycerol-3-P dehydrogenase; GPP ¼ glycerol-3-P phosphatase; GDH ¼ NAD + or NADP-dependent glycerol dehydrogenase; ADH ¼ alcohol dehydrogenase; ALD ¼ acetaldehyde dehydrogenase. nd ¼ not determined; bd ¼ below detection.
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Macrokinetic analysis of engineered strains for glycerol overproduction
and as expected, glycerol became the major fermentation product in the engineered strains. A summary of the kinetic fermentation parameters of wild type and engineered strains is reported in Table 5 . As already noticed in Fig. 2 , a consequence of engineering yeast for high glycerol production was a significant reduction in the growth rate (m max ). However, the m max of the multi-engineered strain HC42 was E30% higher than that of HC16. This relative better growth rate was associated with a glucose consumption and a glycerol production rates that were, respectively, 17% and 55% higher than in HC16 (Table 5) . Moreover, the glycerol yield in HC42 was 10% higher than in HC16 (0.46 g (g glucose) À1 compared to 0.42 g (g glucose) À1 ). In addition, it was not surprising that an elevated production of glycerol was accompanied by a reduction of biomass yield since production of this metabolite is an ATP consuming process. Table 6 gives the yield of major byproducts identified at the end of the fermentation when glucose has been completely consumed. Major changes in yield were obtained for ethanol and glycerol. Besides these metabolites, acetaldehyde and acetoin were not dramatically increased in the HC42 after deletion of ADH1, probably because the aeration process of the bioreactor stripped away acetaldehyde as soon as it was produced. Also, levels of acetate barely changed in HC42 strain that overexpressed ALD3 encoding a cytosolic NAD + -aldehyde dehydrogenase. This lack of effects on acetate levels indicated that this aldehyde dehydrogenase, even present at high levels in the cells, was unable to act on acetaldehyde. Taking into account these by-products, we evaluated the carbon balance. This balance was close to 100% for the wild type, consistent with the fact that under this growth condition, the major fermentation products were ethanol, glycerol, acetate and biomass. In contrast, the carbon balance was around 90-92 in the two engineered strains. Possible reasons for these values may be an underestimation of acetaldehyde, as well as an underestimation of CO 2 production by a higher respiratory activity of the engineered strains, as inferred from transcriptomic data (see below). Yeast strains were cultivated in aerobic batch cultures on a SD medium containing 20 g l À1 glucose. The maximal specific rates were calculated as follows: production of biomass and metabolites along the growth were fitted to a third order polynomic function with R 2 4 0.995. At time interval during the exponential growth phase, the derivative of this equation for glucose consumption, glycerol and ethanol production was determined and divided by that corresponding to the biomass production. The data are the mean of two independent cultures including standard deviation.
The construction of engineered strains for glycerol production raised at least two metabolic issues, one of them is developed in this section. The first challenge was to restore growth of a tpi1D mutant on glucose. The failure of this mutant to grow on glucose was recently attributed to its inositol-less phenotype. This auxotrophy was explained by a potent inhibition of the myo-inositol-6-phosphate (MIP) synthase by high levels DHAP and glycerol-3-P present in mutants defective in triose-phosphate isomerase activity. Accordingly, the growth on a glucose synthetic media could be restored in the presence of inositol (Shi et al., 2005; and our unpublished data) . Here, we found that the growth on glucose of our tpi1D mutant was recovered upon overexpression of GPD1. As shown in Table 7 , this growth recovery can be in part explain by a significant decrease (3-to 4-fold) of DHAP and glycerol-3-P in a tpi1D mutant that overexpressed GPD1 and in a tpi1D GPD1 strain that was also deleted for ADH1 (Table 7) . However, the fact that levels of DHAP and glycerol 3-P did not return to levels in wild type cells suggested that the glycerol flux in the engineered strains was no longer limited at the level of glycerol-3-P dehydrogenase activity (Cronwright et al., 2002; Remize et al., 2001) . Evidence that the glycerol export became the major bottleneck in glycerol production was given by the finding that HC16 and HC42 accumulated 7-10 times more intracellular glycerol than the isogenic wild type (Table 7) . Taking into account the enzymatic and metabolic data reported in Tables 4, 5 and 7, and using the kinetic parameters of GPD and GPP reported by Cronwright et al. (2002), we roughly estimated the flux control coefficient for these three enzymatic steps of the glycerol pathway to be around 0.25-0.30, 0.0-0.10 and 0.65-0.70 for GPD, GPP and glycerol efflux, respectively. Consistent with the fact that the rate-limiting step was shifted at the level of the glycerol efflux, overexpression of FPS1 encoding the major glycerol facilitator (Luyten et al., 1995) in HC42 (to yield FM62 strain) resulted in a 2-fold reduction of intracellular glycerol and in a 10% increase in glycerol productivity (Tables 5 and 7) .
A second metabolic question was to evaluate effects of these molecular manipulations on levels of NAD + and NADH, as it is thought that availability of NADH is determinant for glycerol production (Cambon et al., 2006; Geertman et al., 2006; Overkamp et al., 2002) . As indicated in Table 7 , the genetic manipulation of yeast for glycerol production led to a significant decrease in NADH/NAD + ratio, which was essentially attributed to a 4-to 5-fold reduction in NADH pools. This low NADH/NAD + ratio together may be somehow inhibitory for glycerol production since NAD + acts as a competitive inhibitor of NADH on Gpd1p activity (Albertyn et al., 1992) . Levels of ATP were also lower in engineered strains, and especially in the tpi1D mutant. As ADP and AMP were also measured, this allowed to evaluate the adenylate charge (AC) of the cells according to the Atkinson' equation (Chapman and Atkinson, 1977) . The wild type cells exhibited an AC value of 0.86, which is commonly obtained under normal growth conditions. In contrast, this value dropped to 0.54 in a tpi1D mutant, consistent with its poor growth on glucose. Value of AC was slightly increased to 0.58 in HC16 and The fermentation was carried out in controlled batch reactor at pH 5.0 in SD medium. Glucose and fermentation products were monitored along the growth. The yield is calculated by taking levels of biomass and metabolites that were produced at the time of the complete consumption of glucose, and is expressed in g per 100 g glucose. Values reported are the mean of two independent experiments including standard deviation. CO 2 was calculated from ethanol production. bd ¼ below detection. Glycerol efux is rate limiting in glycero lhyperproducer strains Effects of genetic engineering on NADH availability for glycerol production 0.64 in HC42 strains. Although lower than in wild type cells, these AC values were not significantly low to account for carbon metabolism constraints in the engineered strains.
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Other biochemical effects of our genetic engineering strategy needed some comments. The overexpression of ALD3 did not result in an increase of acetate, which reinforced the recent finding that this ALD3-encoding aldehyde dehydrogenase is really specific in the conversion of 3-aminopropanal to b-alanine (White et al., 2003) . The engineered HC42 (tpi1D adh1 GPD1) strain was found to contain 5 times more alcohol dehydrogenase activity than the adh1D mutant (HC17 mutant, Table 4 ), suggesting a partial release of the glucose-repressed alcohol dehydrogenases. Furthermore, the putative NAD + -dependent glycerol dehydrogenase activity that converts glycerol into dihydroxyacetone (DHA) increased by about 2-fold in HC32 and HC42 strains. Altogether, these enzymatic changes could penalize glycerol production.
To evaluate the effects of molecular manipulations for glycerol production at the genomic scale, we carried out a transcriptomic analysis of the wild type and the multiengineered HC42 strains cultivated in well-aerated batch reactors on a 20 g l À1 glucose medium. Samples were taken early in the log phase, at the maximal growth rate. The culture was repeated 4 times to obtain four independent data sets for statistical analysis (see Material and methods for other details). Using two filtering criteria (ratio 4 1.5 oroÀ1.5, and p value o0.05), a total of 384 differentially expressed genes between HC42 and CEN.PK2a were retained, from which 184 were downregulated and 200 were upregulated (see the complete data sets at http:// biopuce.insa-toulouse.fr/supdata/glycerolgenomics). As a first step for data interpretation, the differentially expressed genes were grouped into 13 functional categories according to the MIPS nomenclature (Mewes et al., 1997; Ruepp et al., 2004) . The procedure was to express the number of up-and down-regulated transcripts in each of the categories as a percentage of the total differentially expressed genes and to compare this functional classification with the functional catalogues of genes described in MIPS. This procedure has the advantage to easily identify the major gene expression remodelling on a genomic scale. As it can be seen in Fig. 3 , the multiple genetic modifications introduced in CEN.PK2 to reorient the carbon flux towards glycerol production resulted in significant enrichment in transcripts of genes that belong to carbon and energy metabolism and to protein synthesis, and in a lesser extent, to ionic homeostasis and cellular communication. In contrast, genes encoding products involved in transcription, cell biogenesis, cell cycle and DNA processing were significantly under-represented. This was further consolidated by GO analysis of the expression data, which authorizes a better identification of the biological processes and cellular components. This analysis revealed that the biological processes altered in the engineered strain concerned cell growth, energy metabolism, ribosomal protein synthesis and ribosomal biogenesis (see Fig S1, in Supplementary data). A closer inspection of genes belonging to the ribosomal protein synthesis and ribosome biogenesis showed that 4 90% of these genes were downregulated, which was consistent with a dramatic reduction of the growth rate of the engineered strain (Table S1 , in Supplementary data).
Other relevant transcriptomic information could be exploited from the list of upregulated genes, whose most of them belong to carbon and energy metabolism ( Table 8) . As expected, ALD3 and GPD1 were overexpressed (respectively 6-and 4-fold), but also GPD2 which encodes the second GPD isoform. The upregulation of INO1 (3.3-fold) encoding MIP synthase as well as GIT1 (1.7-fold) encoding a permease for uptake of glycerophosphoinositol was consistent with the inositol defect induced by deletion of TPI1. This list also contained several genes encoding proteins with NAD + /NADP + binding function (NDI1, PDH1, ALD4, ARA1, GDH2, IDH1, ALD2, ETR1). The ''cellular transport and facilitation'' category stood as another important functional category that was significantly perturbed by genetic engineering for glycerol production (Table S2 , in Supplementary data). Among others, transcript levels of JEN1 which encodes a glucoserepressible lactate/pyruvate permease (Bojunga and Entian, 1999; Casal et al., 1999) was about 2-fold higher in HC42. We also noticed an activation of PHO84 encoding the high affinity phosphate permease (Bun-ya et al., 1991) , which was expected due to the regulatory link between inositol and phosphate metabolism (Almaguer et al., 2003) , and a 2 -fold upregulation of SLT1 encoding the glycerol/H + symporter (Ferreira et al., 2005) . The latter activation may be a consequence of the increased osmotic potential of the cytoplasm due to intracellular accumulation of glycerol.
When the genes listed in Table 8 were clustered according to a regulation by a common transcriptional regulation using YEAStract software (Teixeira et al., 2006) , 30% of them were found to be co-regulated by the HAP2/ 3/4/5 complex, the major transcriptional activator of respiratory genes expression (see Table S2 in Supplementary data). This result was indicative of a partial derepression of the glucose-repressed respiratory activity in the glycerol producer strain. Accordingly, the expression level of some genes known to be repressed by glucose (i.e., COX3; SDH2, SDH3, CYT1, ADR1, etc., see Table 8) were upregulated in the engineered strain.
Discussion
The purpose of this work was to explore an alternative engineering strategy for glycerol production than those previously reported (Campagno et al., 1996 ; Geertman A genome-wide transcriptomic analysis of glycerol hyperproducer strains Nevoigt and Stahl, 1996; Overkamp et al., 2002; Remize et al., 1999) and to evaluate carefully the consequences of this strategy at the metabolic and genomic levels. Our plan involved the overexpression of GPD1 and ALD3 together with deletion of TPI1 and ADH1. This strategy yielded an engineered strain with a glycerol production, which in terms of final yield and maximal productivity rate, was significantly better than that obtained by Overkamp et al. (2002) using the same strain background (0.46 g versus 0.42 g (g glucose) À1 ). In both cases, a tpi1D strain has been used. While Overkamp and coworkers adopted a strategy that promoted glycerol production by preventing regeneration of NADH by mitochondrial NADH dehydrogenases through deletion of NDE1, NDE2 and GUT2 in the tpi1D strain, our approach was more effective for glycerol productivity and growth recovery for at least two reasons. Firstly, Gpd1p is rate limiting in glycerol synthesis, as determined by Metabolic Control analysis (Cronwright et al., 2002) . Thus, its overproduction should stimulate the carbon flux in this pathway. Secondly, the inability of a tpi1 null mutant to grow on glucose has been recently explained by its inositol-defective phenotype. This deficiency is due to the potent inhibition of the MIP synthase that catalyzes the synthesis of inositol-6-P from glucose-6-P, by DHAP and glycerol-3-P, which accumulate to very high levels in a tpi1D mutant (Shi et al., 2005, this study) . In this work, we showed that overexpression of GPD1 significantly reduced DHAP and glycerol-3-P levels, and this reduction in these two metabolites is likely to be more potent than expected in a tpi1D mutant defective of NDE1, NDE2 and GUT2.
However, levels of DHAP and glycerol-3-P in none of the engineered strains returned to those in a wild type strain, suggesting either a problem of NADH recycling or that the rate-limiting step of glycerol production was no longer at the level of GPD enzyme. The finding that engineered strains accumulated large amount of intracellular glycerol pointed to glycerol efflux as the major ratelimiting step in this process. This was confirmed by Metabolic Control analysis, which indicated that the value of the flux control coefficient at the glycerol efflux raised from almost 0.1 in normal condition to 0.70 in condition of hyperproduction of glycerol. Furthermore, intracellular accumulation of glycerol could be reduced 2-to 3-fold by overexpression of FPS1 encoding the major glycerol facilitator (Luyten et al., 1995; Tamas et al., 1999) . However, the fact that this overexpression had a minor effect on glycerol efflux could be explained by the recent finding that high intracellular content of glycerol can mediate its own closure (Karlgren et al., 2005) . Alternatively, it is possible that other aquaglyceroporins are also needed for complete glycerol efflux (Luyten et al., 1995; Petterson et al., 2005) . Accumulation of intracellular glycerol has been also reported to trigger a Hog1-dependent osmoprotective pathway (Albertyn et al., 1994a; Siderius et al., 2000) , which ultimately leads to a slow down of glycolysis and growth rate by a yet uncharacterized mechanism (Blomberg, 2000) . Taken together, these effects may also explain why the overexpression of FPS1 resulted in a weak increase in glycerol productivity As a consequence, the removal of glycerol during its synthesis should be considered as a method to enhance its productivity. Measurement of intracellular metabolites and coenzymes gave also some indications with respect to the metabolic constraints resulting from our engineering strategy. The huge increase of the NAD + /NADH associated with a reduction of ATP levels in the engineered strains indicated that the glycolytic activity in the yeast cells is restrained to its capacity to regenerate NADH. This result indicated that the glycerol production is not only limited by NADH availability but also to the capacity of the yeast cells to regenerate this coenzyme. This interpretation is consistent with the results of Geertman et al. (2006) that showed an increased glycerol production by co-feeding engineered strains with formate, as this latter substrate acts as a direct source of cytosolic NADH. However, taking into account that the rate limiting for glycerol synthesis in engineered strains is reset at the level of glycerol efflux, the co-feeding strategy is not sufficient to increase glycerol productivity.
ARTICLE IN PRESS
Besides these metabolic bottlenecks, our transcriptomic analysis identified several secondary effects of the engineering strategy that may be counterproductive for glycerol production. A major trait was a significant upregulation of genes encoding NAD + /NADP + binding proteins and aldehyde dehydrogenases (i.e., ARA1, NDI1, GDH2, ALD4, PDH1, ALD2, etc). Additionally, the activity of NAD + -dependent glycerol dehydrogenase that converts glycerol into DHA was also increased. Altogether, these metabolic and transcriptomic perturbations could bring at least two negative effects on glycerol production, namely a possible withdrawing of NADH from the glycerol-3-P dehydrogenase enzyme and a potential wasteful glycerol cycle (Molin et al., 2003) . A last but not the least significant effect of the metabolic engineering strategy was a partial derepression of the glucose-repressive genes that belong to the TCA cycle and respiratory activity in the glycerol hyperproducer HC42 strain, which supports the notion that the repression of these cellular functions are dependent on the rate of glucose assimilation (Blank and Sauer, 2004) .
To summarize, we successfully generated a high glycerol producer strain that exhibits a glycerol yield (0.46 g (g glucose) À1 ) and productivity (3.1 mmol glycerol h À1 g À1 dry mass) very similar to those obtained by Geertman et al. (2006) using a different strategy. In the latter case, the authors avoided employing a tpi1D mutant while deleting all pyruvate decarboxylase encoding genes in a strain already depleted for the respiratory oxidation of cytosolic NADH. Curiously, this pyruvate decarboxylase negative engineered strain apparently could grow on a glucose mineral medium without the need of acetate, which was in contrast to a previous work by the same group showing that acetate was necessary in the growth medium of a pdc À mutant to provide acetyl-CoA for lipids synthesis (Flikweert et al., 1999) . In addition and taking into account our above conclusions, it is very likely that the expression of GPD1 has been increased as a consequence of the engineering strategy followed by these authors (Geertman et al., 2006) , since increase of glycerol-3-P dehydrogenase activity is a prerequisite to get a high glycerol flux. Finally, the metabolic engineering for glycerol production incidentally caused several secondary effects that could not be predicted by reconstruction of metabolic networks (Blank et al., 2005; Forster et al., 2003) . Further improvement in production and productivity of glycerol should be possible by combining a co-feeding strategy with formate with the continuous removal of glycerol produced. Eliminating interfering NAD + regenerating reactions and expression of a DHAP-insensitive MIP synthase could be also envisaged to evaluate directly the importance of these metabolic reactions in growth efficiency of glycerol engineered strains.
